Back to SYRE
Bellevue Group AG SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$33.2M
Q3 2026
Peak value
$33.2M
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $260K |
| Q2 2026 | $20.2M |
| Q3 2026 | $606K |
| Q3 2026 | $33.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $33.2M | 373.1K | — | — |
| Q3 2026 | $606K | 6.8K | — | — |
| Q2 2026 | $20.2M | 227.0K | — | — |
| Q2 2026 | $260K | 2.9K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M